KYOWA KIRIN CO. LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,672 JPY | +0.07% |
|
+0.15% | +12.72% |
| May. 07 | Kyowa Kirin's Profit Up 15% in Q1 | MT |
| May. 06 | Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April | MT |
Presenter SpeechKazuyoshi Tachibana (Executives)I am Tachibana. Now I am going to explain the ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:
- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (7.4%).
At the end of 2021, the group had 3 production sites located in Japan (2) and China.
Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,672
JPY
Average target price
3,054
JPY
Spread / Average Target
+14.32%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.72% | 9.13B | |
| +7.22% | 72.81B | |
| -11.75% | 5.13B | |
| +59.61% | 4.99B | |
| +2.62% | 3.9B | |
| -17.54% | 2.48B | |
| +21.35% | 2.42B | |
| -27.82% | 2.32B | |
| +25.13% | 2.17B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- 4151 Stock
- News Kyowa Kirin Co. Ltd.
- Transcript : Kyowa Hakko Kirin Co., Ltd., Q3 2017 Earnings Call, Oct 26, 2017
